CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,754 | -25.3% | 49,421 | -0.4% | 0.04% | -26.5% |
| Q2 2023 | $85,306 | +113.9% | 49,596 | +87.8% | 0.05% | +133.3% |
| Q1 2023 | $39,884 | +0.6% | 26,412 | +6.6% | 0.02% | 0.0% |
| Q4 2022 | $39,660 | -44.1% | 24,787 | -48.2% | 0.02% | -44.7% |
| Q3 2022 | $71,000 | +6.0% | 47,869 | +33.3% | 0.04% | +18.8% |
| Q2 2022 | $67,000 | +67.5% | 35,919 | +145.3% | 0.03% | +113.3% |
| Q1 2022 | $40,000 | -35.5% | 14,644 | +6.5% | 0.02% | -28.6% |
| Q4 2021 | $62,000 | -8.8% | 13,744 | +2.6% | 0.02% | -16.0% |
| Q3 2021 | $68,000 | – | 13,394 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |